Fifth Third Bancorp Viking Therapeutics, Inc. Transaction History
Fifth Third Bancorp
- $25.9 Billion
- Q1 2025
A detailed history of Fifth Third Bancorp transactions in Viking Therapeutics, Inc. stock. As of the latest transaction made, Fifth Third Bancorp holds 200 shares of VKTX stock, worth $5,724. This represents 0.0% of its overall portfolio holdings.
Number of Shares
200
Previous 205
2.44%
Holding current value
$5,724
Previous $8,000
50.0%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding VKTX
# of Institutions
436Shares Held
64.7MCall Options Held
4.75MPut Options Held
3.89M-
Vanguard Group Inc Valley Forge, PA10.2MShares$291 Million0.0% of portfolio
-
Black Rock Inc. New York, NY6.03MShares$172 Million0.01% of portfolio
-
State Street Corp Boston, MA4.93MShares$141 Million0.01% of portfolio
-
Jpmorgan Chase & CO New York, NY3.13MShares$89.5 Million0.01% of portfolio
-
Morgan Stanley New York, NY2.59MShares$74.2 Million0.01% of portfolio
About Viking Therapeutics, Inc.
- Ticker VKTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,688,496
- Market Cap $2.19B
- Description
- Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...